Showing results (261-270 of 976) with videos related to
Sort By:
Pageof 98
Infectious Agents and Cancer|December 18, 2020
Clinical characteristics, outcomes, and risk factors for mortality in hospitalized patients with COVID-19 and cancer history: a propensity score-matched studyMajid Sorouri, Amir Kasaeian, Helia Mojtabavi, et al.Infectious Agents and Cancer|March 12, 2020
Human papillomavirus (HPV) types among Alaska native women attending a colposcopy clinic in Anchorage, Alaska, 2009-2011N J Murphy, L R Bulkow, M Steinau, et al.Infectious Agents and Cancer|October 12, 2020
Loop electrosurgical excision procedure combined with cold coagulation for cervical intraepithelial neoplasia and adenocarcinoma in-situ: a feasible treatment with a low risk of residual/recurrent diseaseEun Jung Yang, Nae Ry Kim, Ji Yeon Choi, et al.Infectious Agents and Cancer|June 11, 2022
Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trialsYi Zhang, Hui Du, Aimin Xiao, et al.Infectious Agents and Cancer|June 23, 2022
Presence of a mouse mammary tumour virus-like in feline lymphomas: a preliminary studyFrancesca Parisi, Francesca Lessi, Michele Menicagli, et al.Infectious Agents and Cancer|June 18, 2022
Hypoalbuminemia predicts inferior outcome in patients with AIDS-related lymphomaJinxin Zhang, Zhiman Xie, Shaohang Cai, et al.Infectious Agents and Cancer|June 15, 2022
The E6 and E7 proteins of beta3 human papillomavirus 49 can deregulate both cellular and extracellular vesicles-carried microRNAsMaria Vincenza Chiantore, Marco Iuliano, Roberta Maria Mongiovì, et al.Infectious Agents and Cancer|June 10, 2021
Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary studyAref Shariati, Shabnam Razavi, Ehsanollah Ghaznavi-Rad, et al.Infectious Agents and Cancer|June 24, 2017
The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer's disease: an overview of pre-clinical studies and translational perspectives in clinical practiceMarco Cascella, Sabrina Bimonte, Maria Rosaria Muzio, et al.Pageof 98